Pathogenesis and progression of microvascular and macrovascular complications in diabetes

Mechanisms of microvascular damage in diabetes

Diabetes leads to significant microvascular and macrovascular complications. Microvascular damage results in retinopathy, nephropathy, and neuropathy, while macrovascular complications increase cardiovascular disease risk.

6/6/20253 min read69 views
loved it
normalintermediatePathology
Understanding Microvascular and Macrovascular Complications in Diabetes

Pathogenesis and Progression of Microvascular and Macrovascular Complications in Diabetes

Mechanisms of Microvascular Damage in Diabetes

Diabetes mellitus is associated with both microvascular and macrovascular complications. Microvascular damage primarily affects small blood vessels, leading to complications such as diabetic retinopathy, nephropathy, and neuropathy.

Pathogenesis of Microvascular Complications

  • Hyperglycemia-induced oxidative stress: Excess glucose generates reactive oxygen species (ROS), leading to endothelial dysfunction.
  • Advanced Glycation End-products (AGEs): Hyperglycemia accelerates non-enzymatic glycation, contributing to basement membrane thickening and vascular permeability.
  • Inflammatory pathways: Chronic inflammation exacerbates vascular injury, increasing the risk of tissue ischemia.

Macrovascular Complications in Diabetes

Macrovascular complications involve large arteries and can lead to cardiovascular disease, stroke, and peripheral artery disease.

Strategies for Prevention

Strict glycemic control, lifestyle modifications, and pharmacological interventions targeting inflammation and oxidative stress help mitigate these complications.

Tags

#diabetic complications#microvascular damage#macrovascular complications#endothelial dysfunction

0 people loved it

Recommended Reads

Explore related articles that might interest you

Pathogenesis, progression, complications, and clinical implications of atherosclerosis and ischemic heart disease
19
11%

Pathogenesis, progression, complications, and clinical implications of atherosclerosis and ischemic heart disease

Read more →
19
Pathogenesis and progression of microvascular and macrovascular complications in diabetes
44
11%

Pathogenesis and progression of microvascular and macrovascular complications in diabetes

Read more →
44
Epidemiology, pathogenesis, risk factors, and clinical progression of type 1 diabetes
46
11%

Epidemiology, pathogenesis, risk factors, and clinical progression of type 1 diabetes

Read more →
46
Pathogenesis and progression of microvascular and macrovascular complications in diabetes
15
11%

Pathogenesis and progression of microvascular and macrovascular complications in diabetes

Read more →
15
Pathogenesis and progression of microvascular and macrovascular complications in diabetes
47
11%

Pathogenesis and progression of microvascular and macrovascular complications in diabetes

Read more →
47
Pathogenesis, progression, and complications of atherosclerosis and ischemic heart disease (IHD)
45
11%

Pathogenesis, progression, and complications of atherosclerosis and ischemic heart disease (IHD)

Read more →
45
Pathophysiology of Hypertension
7
11%

Pathophysiology of Hypertension

Read more →
7
© 2025 MedGloss. All rights reserved.